The News Review:

- Bloomberg.com: Investment Tools
- Queen’s University launches UK’s first Center of Excellence…
- Bloomberg.com: Investment Tools
- Abortion Drug’s ff-label Use May Have Led To Deaths
- HIV Screening Found Cost-effective In lder Adults

Bloomberg.com: Investment Tools
Bloomberg – Jun 18, 2008
The joint venture will be established later this year and will provideservices ranging from research planning and risk assessment throughpreclinical and clinical study design. With an initial focus onearly-stage drug discovery the joint venture will also be positioned tosupport later-stage clinical development including coordination with researchsites data management monitoring and reporting for clinical researchprograms. Expansion of the joint venture's operation will include providingcounsel and support related to clinical research regulatory guidelines andregulatory review procedures in China. "As the world's most rapidly expanding market for healthcare productsChina is poised for explosive growth in research in the years aheadespecially related to early stage drug discovery. BCMU is a well establishedresearch center with drug discovery experience and significant capital andresources. We look forward to building a successful CRS business with Immtechto meet the increasing demand in the market" said Mr. Guo the Director ofBCMU Resource Management Center.

Queen’s University launches UK’s first Center of Excellence…
EurekAlert – EurekAlert (press release) – Jun 18, 2008
” Essential to the success of the bid was the support of an important group of key stakeholders including the ffice of the Chief Medical fficer the Community Development and Health Network the DHSSPSNI Research and Development ffice the Health Promotion Agency NI the Northern Ireland Statistics and Research Agency and the Discovery Centre W5 who will help disseminate the research to the public. Barbary Cook Chair of the Community Development and Health Network said: “We are delighted to be involved with the Centre of Excellence and look forward to seeing communities fully connected to the research and practice development of the Centre. A partnership of funders under the umbrella of the UK Clinical Research Collaboration (UKCRC) provided the £20 million investment needed to establish the five Centres of Excellence. The funding group is lead by the Economic and Social Research Council (ESRC). Funding partners are the Health and Social Care Research and Development ffice for Northern Ireland the British Heart Foundation Cancer Research UK Economic and Social Research Council Medical Research Council National Institute for Health Research Wales ffice of Research and Development – Welsh Assembly Government and the Wellcome Trust.

Bloomberg.com: Investment Tools
Bloomberg – Jun 18, 2008
About DATATRAK International DATATRAK International Inc. is a worldwide technology company focused onthe provision of multi-component eClinical solutions and related services forthe clinical trials industry. The Company delivers a complete portfolio ofsoftware products that were created in order to accelerate clinical researchdata from investigative sites to clinical trial sponsors and ultimately theFDA faster and more efficiently than manual methods or loosely integratedtechnologies. DATATRAK's eClinical software suite can be deployed worldwidethrough an ASP offering or in a licensed Enterprise Transfer model that fullyempowers its clients. The DATATRAK software suite and its earlier versionshave successfully supported hundreds of international clinical trialsinvolving thousands of clinical research sites and encompassing tens ofthousands of patients in 59 countries. DATATRAK International Inc. 's productsuite has been utilized in some aspect of the clinical development of 16 drugsand one medical device that have received regulatory approval from either theUnited States Food and Drug Administration or counterpart European bodies.

Abortion Drug’s ff-label Use May Have Led To Deaths
Science Daily – Science Daily (press release) – Jun 18, 2008
Because prostaglandins are made in abundance in the pregnant uterus and have already been implicated in infections we are increasingly realizing their potent immune regulatory actions" Aronoff says. "Since infections are a great cause of illness and death in pregnancy this seems to be a very ripe area to study in efforts to develop better preventive and therapeutic strategies against the complications of pregnancy. "Funding for the research came from the National Institutes of Health the Central Society for Clinical Research and the Doris Duke Clinical Scientist Development Award Program. Journal reference:Aronoff David M. Hao Yibai Chung Jooho Coleman Nicole Lewis Casey Peres Camila M. Chen Gwo-Hsiao Flamand Nicolas Brock Thomas G.

HIV Screening Found Cost-effective In lder Adults
Science Daily – Science Daily (press release) – Jun 18, 2008
associate professor of medicine at the Duke Clinical Research Institute and the lead author of the study appearing in the June 17 issue of the Annals of Internal Medicine. The Centers for Disease Control recommends HIV screening for patients aged 13 to 64 and Sanders says it is clearly cost-effective to screen younger populations — even if the prevalence of the disease is low — because any benefits will be enjoyed over a much longer period. But HIV is less prevalent among older Americans. In addition older patients are also more likely to have fewer sex partners and more life-threatening conditions that might make routine screening less economically attractive. "Until now we’ve assumed that screening made a lot of sense in younger people but we really didn’t know if it was a good use of our healthcare resources in older folks" says Sanders.